1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Eanm Research Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma Sorafenib - Medullary Thyroid Carcinoma | Phase 2 | Withdrawn | Eanm Research Ltd | 2012-10-01 | 2013-05-17 |
Sorafenib (1)
Germany (1)